riluzole has been researched along with Cognition Disorders in 7 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In part 1, I give an update on the care of patients with amyotrophic lateral sclerosis, including ways to speed diagnosis, optimal use of riluzole, multidisciplinary teams, mechanical ventilation, gastrostomy tubes, lipid-lowering agents and symptom management." | 4.86 | Amyotrophic lateral sclerosis: current practice and future treatments. ( Bedlack, RS, 2010) |
| "Riluzole-treated TauP301L mice exhibited improved performance in the water radial arm maze and the Morris water maze, associated with a decrease in glutamate release and an increase in glutamate uptake in the dentate gyrus, cornu ammonis 3 (CA3), and cornu ammonis 1 (CA1) regions of the hippocampus." | 1.42 | Riluzole rescues glutamate alterations, cognitive deficits, and tau pathology associated with P301L tau expression. ( Gerhardt, GA; Hickman, JE; Hunsberger, HC; Libell, EM; Reed, MN; Rudy, CC; Speer, RR; Weitzner, DS, 2015) |
| "Patient 2 showed persecution paranoia and motor impersistence at the age of 42." | 1.34 | Monozygotic twins suffering from Huntington's disease show different cognitive and behavioural symptoms. ( Garamendi, I; Gómez-Esteban, JC; Lezcano, E; Pérez, T; Tijero, B; Velasco, F; Zarranz, JJ, 2007) |
| "Treatment with Riluzole had no significant effect on posttraumatic lesion volume." | 1.29 | Riluzole, a novel neuroprotective agent, attenuates both neurologic motor and cognitive dysfunction following experimental brain injury in the rat. ( McIntosh, TK; Perri, BR; Smith, DH; Stutzmann, JM; Voddi, M, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hunsberger, HC | 1 |
| Weitzner, DS | 1 |
| Rudy, CC | 1 |
| Hickman, JE | 1 |
| Libell, EM | 1 |
| Speer, RR | 1 |
| Gerhardt, GA | 1 |
| Reed, MN | 1 |
| Whitcomb, DJ | 1 |
| Molnár, E | 1 |
| Nourbakhsh, B | 1 |
| Nunan-Saah, J | 1 |
| Maghzi, AH | 1 |
| Julian, LJ | 1 |
| Spain, R | 1 |
| Jin, C | 1 |
| Lazar, A | 1 |
| Pelletier, D | 1 |
| Waubant, E | 1 |
| Stukovnik, V | 1 |
| Zidar, J | 1 |
| Podnar, S | 1 |
| Repovs, G | 1 |
| Bedlack, RS | 1 |
| Gómez-Esteban, JC | 1 |
| Lezcano, E | 1 |
| Zarranz, JJ | 1 |
| Velasco, F | 1 |
| Garamendi, I | 1 |
| Pérez, T | 1 |
| Tijero, B | 1 |
| McIntosh, TK | 1 |
| Smith, DH | 1 |
| Voddi, M | 1 |
| Perri, BR | 1 |
| Stutzmann, JM | 1 |
1 review available for riluzole and Cognition Disorders
| Article | Year |
|---|---|
Amyotrophic lateral sclerosis: current practice and future treatments.
Topics: Amyotrophic Lateral Sclerosis; Biomarkers; Cognition Disorders; Evidence-Based Medicine; Forecasting | 2010 |
6 other studies available for riluzole and Cognition Disorders
| Article | Year |
|---|---|
Riluzole rescues glutamate alterations, cognitive deficits, and tau pathology associated with P301L tau expression.
Topics: Alzheimer Disease; Animals; Brain Chemistry; Cognition Disorders; Excitatory Amino Acid Antagonists; | 2015 |
Is riluzole a new drug for Alzheimer's disease?
Topics: Animals; Cognition Disorders; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Neuroprotect | 2015 |
Longitudinal associations between MRI and cognitive changes in very early MS.
Topics: Adult; Cognition Disorders; Disease Progression; Female; Humans; Longitudinal Studies; Magnetic Reso | 2016 |
Amyotrophic lateral sclerosis patients show executive impairments on standard neuropsychological measures and an ecologically valid motor-free test of executive functions.
Topics: Algorithms; Amyotrophic Lateral Sclerosis; Back; Cognition Disorders; Depressive Disorder; Diagnosti | 2010 |
Monozygotic twins suffering from Huntington's disease show different cognitive and behavioural symptoms.
Topics: Adult; Anxiety; Behavioral Symptoms; Brain; Chorea; Cognition Disorders; Humans; Huntington Disease; | 2007 |
Riluzole, a novel neuroprotective agent, attenuates both neurologic motor and cognitive dysfunction following experimental brain injury in the rat.
Topics: Animals; Body Water; Brain Edema; Brain Injuries; Cognition Disorders; Male; Movement Disorders; Neu | 1996 |